Sarepta Therapeutics, Inc. (SRPT): Shareholders' Equity
$1.14B
As of 2025-12-31
$1.53B
As of 2026-06-30
+43.6%
3-year compound annual growth
+8.4%
5-year compound annual growth
+19.6%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.14B | -25.3% | 2026-03-02, Balance as of period end |
| 2024-12-31 | $1.53B | +77.8% | 2026-03-02, Balance as of period end |
| 2023-12-31 | $859.34M | +123.2% | 2026-03-02, Balance as of period end |
| 2022-12-31 | $384.95M | -58.5% | 2025-02-28, Balance as of period end |
| 2021-12-31 | $928.01M | +21.8% | 2024-02-28, Balance as of period end |
| 2020-12-31 | $761.76M | -6.9% | 2023-02-28, Balance as of period end |
| 2019-12-31 | $818.19M | -20.7% | 2022-03-01, Balance as of period end |
| 2018-12-31 | $1.03B | +30.8% | 2021-03-01, Balance as of period end |
| 2017-12-31 | $789.22M | +134.4% | 2020-02-26, Balance as of period end |
| 2016-12-31 | $336.69M | +76.9% | 2019-02-28, Balance as of period end |
| 2015-12-31 | $190.35M | -23.1% | 2018-03-01, Balance as of period end |
| 2014-12-31 | $247.65M | +0.2% | 2016-02-25, Balance as of period end |
| 2013-12-31 | $247.19M | +99.9% | 2015-02-26, Balance as of period end |
| 2012-12-31 | $123.68M | +298.7% | 2014-03-03, Balance as of period end |
| 2011-12-31 | $31.02M | n/m | 2013-03-15, Balance as of period end |
| 2010-12-31 | -$2.82M | n/m | 2012-03-13, Balance as of period end |
| 2009-12-31 | $23.63M | +50.2% | 2013-03-15, Balance as of period end |
| 2008-12-31 | $15.73M | n/a | 2012-03-13, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | $1.14B | -25.3% |
| Royalty Pharma plc (RPRX) | 2025-12-31 | $9.71B | -6.1% |
| PTC Therapeutics, Inc. (PTCT) | 2025-12-31 | -$205.31M | n/m |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | -$70.79M | n/m |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $7.10B | +10.1% |
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $385.48M | +34.9% |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $6.09B | +7.6% |
| Alkermes plc. (ALKS) | 2025-12-31 | $1.82B | +24.2% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $789.18M | n/m |
Compare SRPT, RPRX, PTCT, AMRX side by side · Screen every company in Pharmaceutical Preparations ↗